Thomas Wisniewski
Thomas Wisniewski
Professor of Neurology, Pathology and Psychiatry, New York University School of Medicine
Verified email at - Homepage
Cited by
Cited by
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature
PT Nelson, I Alafuzoff, EH Bigio, C Bouras, H Braak, NJ Cairns, ...
Journal of Neuropathology & Experimental Neurology 71 (5), 362-381, 2012
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
T Wisniewski, B Frangione
Neuroscience letters 135 (2), 235-238, 1992
Clearance systems in the brain—implications for Alzheimer disease
JM Tarasoff-Conway, RO Carare, RS Osorio, L Glodzik, T Butler, ...
Nature reviews neurology 11 (8), 457-470, 2015
Primary age-related tauopathy (PART): a common pathology associated with human aging
JF Crary, JQ Trojanowski, JA Schneider, JF Abisambra, EL Abner, ...
Acta neuropathologica 128 (6), 755-766, 2014
A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions
P Marambaud, J Shioi, G Serban, A Georgakopoulos, S Sarner, V Nagy, ...
The EMBO journal 21 (8), 1948-1956, 2002
Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation
CA Lemere, JK Blusztajn, H Yamaguchi, T Wisniewski, TC Saido, ...
Neurobiology of disease 3 (1), 16-32, 1996
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
JW Um, HB Nygaard, JK Heiss, MA Kostylev, M Stagi, A Vortmeyer, ...
Nature neuroscience 15 (9), 1227-1235, 2012
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.
T Wisniewski, EM Castano, A Golabek, T Vogel, B Frangione
The American journal of pathology 145 (5), 1030, 1994
Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein
JW Um, AC Kaufman, M Kostylev, JK Heiss, M Stagi, H Takahashi, ...
Neuron 79 (5), 887-902, 2013
The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes
J Wegiel, I Kuchna, K Nowicki, H Imaki, J Wegiel, E Marchi, SY Ma, ...
Acta neuropathologica 119 (6), 755-770, 2010
Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
DA Sanan, KH Weisgraber, SJ Russell, RW Mahley, D Huang, ...
The Journal of clinical investigation 94 (2), 860-869, 1994
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease
L Mosconi, R Mistur, R Switalski, WH Tsui, L Glodzik, Y Li, E Pirraglia, ...
European journal of nuclear medicine and molecular imaging 36 (5), 811-822, 2009
Alzheimer’s disease: experimental models and reality
E Drummond, T Wisniewski
Acta neuropathologica 133 (2), 155-175, 2017
Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides
C Soto, RJ Kascsak, GP Saborío, P Aucouturier, T Wisniewski, F Prelli, ...
The Lancet 355 (9199), 192-197, 2000
The cerebrospinal-fluid soluble form of Alzheimer's amyloid β is complexed to SP-40, 40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex
J Ghiso, E Matsubara, A Koudinov, NH Choi-Miura, M Tomita, ...
Biochemical Journal 293 (1), 27-30, 1993
Amyloid β protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization
I Klyubin, V Betts, AT Welzel, K Blennow, H Zetterberg, A Wallin, ...
Journal of Neuroscience 28 (16), 4231-4237, 2008
Apolipoprotein E: binding to soluble Alzheimer′ s β-amyloid
T Wisniewski, A Golabek, E Matsubara, J Ghiso, B Frangione
Biochemical and biophysical research communications 192 (2), 359-365, 1993
Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice
EM Sigurdsson, H Scholtzova, PD Mehta, B Frangione, T Wisniewski
The American journal of pathology 159 (2), 439-447, 2001
Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation
T Wisniewski, J Ghiso, B Frangione
Biochemical and biophysical research communications 179 (3), 1247-1254, 1991
Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E
EM Castano, F Prelli, T Wisniewski, A Golabek, RA Kumar, C Soto, ...
Biochemical Journal 306 (2), 599-604, 1995
The system can't perform the operation now. Try again later.
Articles 1–20